Neuroendocrinology Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
CRNX | D | Crinetics Pharmaceuticals, Inc. | -2.94 | |
RANI | D | Rani Therapeutics Holdings, Inc. | -2.84 |
Related Industries: Biotechnology
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
SBIO | D | ALPS Medical Breakthroughs ETF | 2.59 | |
PTH | C | Invesco DWA Healthcare Momentum ETF | 1.38 | |
MMSC | B | First Trust Multi-Manager Small | 1.13 | |
BBC | D | Virtus LifeSci Biotech Clinical Trials ETF | 0.86 | |
FTHI | A | First Trust High Income ETF | 0.77 |
Compare ETFs
Date | Stock | Title |
---|---|---|
Jun 28 | RANI | RANI: GLP-2 Deal Announced |
- Neuroendocrinology
Neuroendocrinology is the branch of biology (specifically of physiology) which studies the interaction between the nervous system and the endocrine system, that is how the brain regulates the hormonal activity in the body. The nervous and endocrine systems often act together in a process called neuroendocrine integration, to regulate the physiological processes of the human body. Neuroendocrinology arose from the recognition that the brain, especially the hypothalamus, controls secretion of pituitary gland hormones, and has subsequently expanded to investigate numerous interconnections of the endocrine and nervous systems.
The neuroendocrine system is the mechanism by which the hypothalamus maintains homeostasis, regulating reproduction, metabolism, eating and drinking behaviour, energy utilization, osmolarity and blood pressure.
Recent Comments
- TraderMike on Bollinger Band Squeeze
- TraderMike on Bollinger Band Squeeze
- OpenCat584 on Bollinger Band Squeeze
- Dr_Duru on Expansion Breakout
- TraderMike on New Scans: Strong, Oversold Stocks and Weak, Overbought Stocks
From the Blog
Featured Articles